FDA 483 - Elizabeth Plimack, MD, MS - September 26, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Elizabeth Plimack, MD, MS in Philadelphia, PA, revealed that an investigation was not conducted in accordance with the signed statement of investigator and investigational plan. This included failures to submit tumor tissue for biomarker analysis, collect various blood specimens, and perform electrocardiograms for multiple study subjects as required by the protocol. These deviations indicate a significant lack of adherence to the established investigational plan.
ID · c7439c13-cc48-4429-8c41-87382c5bdff8